Sulis Therapeutics ApS — Credit Rating and Financial Key Figures

Sulis Therapeutics ApS (CVR number: 44445832) is a company from KØBENHAVN. The company recorded a gross profit of -167.1 kEUR in 2024. The operating profit was -225.3 kEUR, while net earnings were -202.3 kEUR. The profitability of the company measured by Return on Assets (ROA) was -58.1 %, which can be considered poor and Return on Equity (ROE) was -58.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -7.9 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Sulis Therapeutics ApS's liquidity measured by quick ratio was 12.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.